A new mother asks the nurse about the white substance" covering her infant. The nurse explains that the purpose of vernix caseosa is to:

A) Mother Rh-, baby Rh+:
RhoGAM (Rh immune globulin) is administered to a mother who is Rh-negative and has delivered a baby who is Rh-positive. If the Rh-negative mother is exposed to Rh-positive blood (via the baby’s blood during delivery), her immune system may start producing antibodies against Rh-positive cells, which could affect future pregnancies. The RhoGAM injection works by preventing the mother from developing these antibodies, thereby protecting any subsequent pregnancies from hemolytic disease of the newborn (HDN) in which the mother’s antibodies attack the baby’s red blood cells. This is a crucial preventive measure to avoid sensitization to Rh-positive blood.

B) Mother Rh-, baby Rh-:
If both the mother and baby are Rh-negative, there is no concern about the development of antibodies because there is no exposure to Rh-positive blood. Therefore, RhoGAM is not necessary in this situation.

C) Mother Rh+, baby Rh+:
In this scenario, the mother is Rh-positive, so she cannot develop antibodies against Rh-positive blood, regardless of the baby's Rh status. Hence, RhoGAM is not required because there is no risk of Rh incompatibility.
D) Mother Rh+, baby Rh-:
Since the mother is Rh-positive, there is no risk of her immune system attacking an Rh-negative baby’s red blood cells. Thus, RhoGAM is not needed in this case either.

A) Bacteria that synthesize vitamin K are not present in the newborn's intestinal tract:
Newborns are born with a sterile gastrointestinal tract, meaning they do not yet have the intestinal bacteria necessary to synthesize vitamin K. Vitamin K is essential for the activation of clotting factors, and without sufficient vitamin K, newborns are at risk for bleeding disorders, particularly a condition known as vitamin K deficiency bleeding (VKDB). Administering vitamin K by injection shortly after birth ensures the baby has adequate levels to prevent bleeding.
B) Vitamin K prevents the synthesis of prothrombin in the liver and must be given by injection:
This statement is incorrect. Vitamin K does not prevent the synthesis of prothrombin; rather, it is essential for the liver to synthesize clotting factors, including prothrombin. The injection of vitamin K in newborns is necessary to provide adequate levels of vitamin K to support proper blood clotting, as newborns cannot produce enough on their own at birth due to the absence of gut bacteria that normally produce it.

C) The supply of vitamin K is inadequate for at least 12 months, and the newborn must be supplemented throughout infancy:
While it is true that newborns have a limited supply of vitamin K at birth, this deficiency is typically addressed with a single injection given shortly after birth. Supplementing vitamin K throughout infancy is generally not required, as the infant's gastrointestinal tract will start to develop the necessary bacteria to synthesize vitamin K within the first few weeks to months of life. The first dose of vitamin K prevents bleeding disorders, and in most cases, additional supplementation is not necessary.

D) Most mothers have a diet deficient in vitamin K, which results in the infant being deficient:
While maternal diet does play a role in the newborn's initial vitamin K levels, it is not the primary reason for the deficiency. Vitamin K deficiency in newborns is primarily due to the lack of gut bacteria necessary to produce it, rather than maternal diet. The practice of administering vitamin K to all newborns ensures that they receive adequate levels to prevent bleeding, regardless of maternal dietary intake.